These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28256103)

  • 1. Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations".
    Mestre TA; van Duijn E; Davis AM; Bachoud-Lévi AC; Busse M; Anderson KE; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2017 Mar; 32(3):482. PubMed ID: 28256103
    [No Abstract]   [Full Text] [Related]  

  • 2. Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.
    Mestre TA; van Duijn E; Davis AM; Bachoud-Lévi AC; Busse M; Anderson KE; Ferreira JJ; Mahlknecht P; Tumas V; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2016 Oct; 31(10):1466-1478. PubMed ID: 27296904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor analysis of behavioural symptoms in Huntington's disease.
    Rickards H; De Souza J; van Walsem M; van Duijn E; Simpson SA; Squitieri F; Landwehrmeyer B;
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):411-2. PubMed ID: 20392980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.
    Thompson JC; Harris J; Sollom AC; Stopford CL; Howard E; Snowden JS; Craufurd D
    J Neuropsychiatry Clin Neurosci; 2012; 24(1):53-60. PubMed ID: 22450614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease.
    Van Liew C; Gluhm S; Goldstein J; Cronan TA; Corey-Bloom J
    Psychiatry; 2013; 76(4):323-35. PubMed ID: 24299091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminant analysis of Beck Depression Inventory and Hamilton Rating Scale for Depression in Huntington's disease.
    Rickards H; De Souza J; Crooks J; van Walsem MR; van Duijn E; Landwehrmeyer B; Squitieri F; Simpson SA;
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):399-402. PubMed ID: 22231310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
    Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T
    Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease.
    Anderson KE; Louis ED; Stern Y; Marder KS
    Am J Psychiatry; 2001 May; 158(5):799-801. PubMed ID: 11329405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease.
    Vassos E; Panas M; Kladi A; Vassilopoulos D
    Biol Psychiatry; 2007 Dec; 62(12):1347-52. PubMed ID: 17610848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease and behavioral dyscontrol.
    Chua SM; Lee TS
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):451-f.e10-451.e11. PubMed ID: 21037138
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives.
    Soliveri P; Monza D; Piacentini S; Paridi D; Nespolo C; Gellera C; Mariotti C; Albanese A; Girotti F
    Neurol Sci; 2002 Sep; 23 Suppl 2():S105-6. PubMed ID: 12548365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral symptoms associated with Huntington's disease.
    Anderson KE; Marshall FJ
    Adv Neurol; 2005; 96():197-208. PubMed ID: 16383221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's Disease Gene Expansion Carriers Are Aware of Their Degree of Apathy.
    Baake V; van Duijn E; Roos RAC
    J Neuropsychiatry Clin Neurosci; 2018; 30(3):183-187. PubMed ID: 29843585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
    Oulis P; Mourikis I; Konstantakopoulos G; Papageorgiou SG; Kouzoupis AV
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352c.e4-352.e5. PubMed ID: 20686147
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease.
    Leroi I; O'Hearn E; Marsh L; Lyketsos CG; Rosenblatt A; Ross CA; Brandt J; Margolis RL
    Am J Psychiatry; 2002 Aug; 159(8):1306-14. PubMed ID: 12153822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of apathy in Huntington's disease.
    van Duijn E; Reedeker N; Giltay EJ; Roos RA; van der Mast RC
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):287-94. PubMed ID: 20686135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease stage, but not sex, predicts depression and psychological distress in Huntington's disease: A European population study.
    Dale M; Maltby J; Shimozaki S; Cramp R; Rickards H;
    J Psychosom Res; 2016 Jan; 80():17-22. PubMed ID: 26721543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Acetylcysteine for Huntington's?
    Berk M
    Aust N Z J Psychiatry; 2015 Nov; 49(11):1071-2. PubMed ID: 26377749
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical periods of suicide risk in Huntington's disease.
    Paulsen JS; Hoth KF; Nehl C; Stierman L
    Am J Psychiatry; 2005 Apr; 162(4):725-31. PubMed ID: 15800145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.